1ACHC Stock Chart & Stats
€24.60
-€0.60(-2.16%)
At close: 4:00 PM EDT
€24.60
-€0.60(-2.16%)
Day’s Range― - ―
52-Week Range€6.00 - €46.00
Previous CloseN/A
Volume0.00
Average Volume (3M)57.00
Market Cap
€2.30B
Enterprise Value€5.30K
Total Cash (Recent Filing)€171.29M
Total Debt (Recent Filing)€2.56B
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Nov 04, 2026EPS Estimate
0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.45
Shares Outstanding93,100,270
10 Day Avg. Volume63
30 Day Avg. Volume57
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.66
Price to Sales (P/S)0.39
P/FCF Ratio-2.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€30.83Price Target Upside25.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)1.32
Revenue Forecast (FY)€2.97B
Bulls Say, Bears Say
Bulls Say
Capacity ExpansionPlanned bed additions and newly opened joint-venture facilities expand Acadia’s treatment capacity and geographic reach. Over time, successful occupancy ramps can increase revenue from the existing behavioral-health demand base while improving utilization of the company’s operating infrastructure.
Underlying Revenue GrowthUnderlying growth remains positive after removing supplemental-payment timing effects, with same-facility performance also expanding. This indicates that volume, pricing, and facility execution are supporting the core business beyond temporary reimbursement timing, strengthening the revenue foundation.
Cash Flow And Debt ReductionQuarterly free cash flow and substantial debt repayment demonstrate an ability to generate liquidity when operating performance and capital spending are favorable. Sustained cash conversion would improve financial flexibility, support facility investment, and gradually reduce leverage-related constraints.
Bears Say
Weak Profitability And Revenue TrendThe sharp swing from prior profitability to a substantial trailing loss indicates that Acadia’s earnings power is currently weak and volatile. Revenue contraction further limits operating leverage, making it harder for the company to fund expansion and absorb cost pressures from internal cash generation.
Elevated Leverage And Inconsistent Cash ConversionHigher leverage reduces financial flexibility at a time when earnings remain unstable, while negative trailing free cash flow shows that operating cash has not consistently covered investment needs. This combination can constrain capital allocation and make balance-sheet improvement dependent on stronger future execution.
Rising Professional Liability CostsThe materially higher liability-cost outlook creates a recurring margin headwind rather than a purely one-time expense. Uncertainty about additional actuarial adjustments makes future earnings less predictable and could divert cash from expansion, debt reduction, or other strategic priorities.
Acadia Healthcare News
1ACHC FAQ
What was Acadia Healthcare’s price range in the past 12 months?
Acadia Healthcare lowest stock price was €6.00 and its highest was €46.00 in the past 12 months.
What is Acadia Healthcare’s market cap?
Acadia Healthcare’s market cap is €2.30B.
When is Acadia Healthcare’s upcoming earnings report date?
Acadia Healthcare’s upcoming earnings report date is Nov 04, 2026 which is in 43 days.
How were Acadia Healthcare’s earnings last quarter?
Acadia Healthcare released its earnings results on Jul 28, 2026. The company reported €0.33 earnings per share for the quarter, beating the consensus estimate of €0.3 by €0.029.
Is Acadia Healthcare overvalued?
According to Wall Street analysts Acadia Healthcare’s price is currently Undervalued.
Does Acadia Healthcare pay dividends?
Acadia Healthcare does not currently pay dividends.
What is Acadia Healthcare’s EPS estimate?
Acadia Healthcare’s EPS estimate is 0.41.
How many shares outstanding does Acadia Healthcare have?
Acadia Healthcare has 93,100,270 shares outstanding.
What happened to Acadia Healthcare’s price movement after its last earnings report?
Acadia Healthcare reported an EPS of €0.33 in its last earnings report, beating expectations of €0.3. Following the earnings report the stock price went down -13.986%.
Which hedge fund is a major shareholder of Acadia Healthcare?
Currently, no hedge funds are holding shares in IT:1ACHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Acadia Healthcare Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€30.83 (25.33% Upside)
€30.83 (25.33% Upside)
Blogger Sentiment
Bullish
IT:1ACHC Sentiment 71%
Sector Average 63%
Sector Average 63%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.36%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-12.08%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Acadia Healthcare
Acadia Healthcare Company, Inc. specializes in delivering a comprehensive range of behavioral health services, with its operations spanning the United States and Puerto Rico. Patients receive care in diverse environments, including acute inpatient psychiatric hospitals, specialized treatment facilities, long-term residential centers, and outpatient clinics. As of March 31, 2022, the company managed an extensive network consisting of 238 behavioral healthcare facilities, collectively providing approximately 10,600 beds. Established in 2005, Acadia Healthcare is headquartered in Franklin, Tennessee.
1ACHC Company Deck
1ACHC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was predominantly positive: management reported results at or above guidance, strong free cash flow, substantial debt reduction, improving performance from new facilities, operational gains, and confidence in the full-year outlook. Offsetting issues included flat reported revenue, the impact of New York Medicaid changes, a significant professional liability reserve adjustment, CTC performance below expectations, start-up losses, and uncertainty around government investigation costs. The highlights significantly outweighed the lowlights.View all IT:1ACHC earnings summaries1ACHC Stock 12 Month Forecast
Average Price Target
€30.83
▲(25.33% Upside)
Technical Analysis
Community Health
―
HCA Healthcare
―
Healthcare Services
―
Universal Health
―
Lifestance Health Group
―